Tacrofoli 0.25 Capsule: A High-Value PCD Pharma Franchise Opportunity

About Tacrolimus 0.25mg: The Cornerstone of Transplant Care

A Stable and High-Demand Market for Immunosuppressants

Why Tacrofoli 0.25 is a Profitable Investment for Distributors

Partnering with a Leading PCD Pharma Company
Launch Your Profitable Business in the Specialty Segment

Home/Products /tacrolimus-0-point-25mg-capsule

Tacrofoli 0.25 Capsule

Composition : Tacrolimus (0.25mg) Capsule

Dosage Form : Capsule

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Tacrofoli 0.25 Capsule, containing Tacrolimus (0.25mg), is a highly specialized and vital immunosuppressant medication. It is a cornerstone of modern organ transplantation, used to prevent the body from rejecting newly transplanted organs such as the kidney, liver, or heart. The low dose formulation of 0.25mg is crucial for long-term maintenance therapy, ensuring consistent efficacy with a lower risk of adverse effects. This product meets a critical and non-negotiable medical need, guaranteeing a stable and ongoing demand in the market.

Read More

About the Product

Tacrofoli 0.25 Capsule, containing Tacrolimus (0.25mg), is a highly specialized and vital immunosuppressant medication. It is a cornerstone of modern organ transplantation, used to prevent the body from rejecting newly transplanted organs such as the kidney, liver, or heart. The low dose formulation of 0.25mg is crucial for long-term maintenance therapy, ensuring consistent efficacy with a lower risk of adverse effects. This product meets a critical and non-negotiable medical need, guaranteeing a stable and ongoing demand in the market.

May include headache, diarrhea, nausea, abdominal pain, or dizziness. Rarely, allergic reactions or changes in liver function tests may occur.

Peptic ulcer disease (gastric and duodenal ulcers) GERD (Gastroesophageal reflux disease) Zollinger-Ellison syndrome Prevention of stress-induced gastritis or ulcers in critically ill patients

Use only under medical supervision. Administer via intravenous route as prescribed. Monitor for signs of allergic reactions or electrolyte imbalance during prolonged use.

Store below 25°C in a cool, dry place away from light. Protect the vial from moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation